10 Stocks With Unexpected Gains
Ten stocks kicked off the trading week with significant gains, mirroring Wall Street's broader optimism, as investors cheered strong US jobs data while waiting on the sidelines for developments on the...
Soleno Therapeutics Inc (SLNO)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | VenBio Select Advisor Kurt Von Emster | 2,900,000 | $134,270,000 | +13% | 1.32% |
| 2. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 1,314,002 | $60,838,293 | +53% | 2.01% |
| 3. | Millennium Management Israel Englander | 1,236,321 | $57,241,662 | +27% | 0.02% |
| 4. | Commodore Capital Egen Atkinson And Michael Kramarz | 1,200,000 | $55,560,000 | -12% | 3.7% |
| 5. | Braidwell LP Alex Karnal | 1,187,859 | $54,997,872 | -8% | 1.76% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $20.00 | 250,000 | $5,000,000.00 | 3,074,542 | 2023-09-28 | Filing | |
| $21.00 | 36,939 | $775,719.00 | 2,824,542 | 2023-09-26 | Filing | |
| $20.03 | 117,996 | $2,363,459.88 | 2,787,603 | 2023-09-26 | Filing | |
| $19.11 | 88,685 | $1,694,770.35 | 2,669,607 | 2023-09-26 | Filing | |
| $18.24 | 52,691 | $961,083.84 | 2,580,922 | 2023-09-26 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $31.72 | 558 | $17,699.03 | 64,507 | 2026-03-27 | Filing | |
| $31.04 | 2,100 | $65,180.64 | 65,065 | 2026-03-27 | Filing | |
| $30.04 | 4,864 | $146,099.97 | 67,165 | 2026-03-27 | Filing | |
| $31.72 | 488 | $15,478.73 | 39,823 | 2026-03-27 | Filing | |
| $31.04 | 1,838 | $57,048.58 | 40,311 | 2026-03-27 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 616,217 | $20,630,945 | 0.02% | |
| 2. | 48,261 | $1,615,778 | 0.29% | |
| 3. | 47,731 | $1,598,034 | 0.03% | |
| 4. | 38,730 | $1,296,680 | 0.01% | |
| 5. | 35,607 | $1,192,122 | 0.04% |
News See All
Soleno Therapeutics’ (SLNO) Investor Sentiment Subdued Amid Growth Concerns
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” fourth-quarter 2025 investor letter.
7 Best Small-Cap Healthcare Stocks to Buy According to Hedge Funds
In this article, we will look at the best small-cap healthcare stocks to buy according to hedge funds.
H.C. Wainwright Lowers PT on Soleno (SLNO), Keeps a Buy Rating
Soleno Therapeutics, Inc. (NASDAQ:SLNO) is one of the Best Small-Cap Growth Stocks to Buy According to Hedge Funds. On March 4, H.C.
12 Best Small-Cap Growth Stocks to Buy According to Hedge Funds
On February 5, Simeon Hyman, Global Investment Strategist at ProShares, appeared on a Schwab Network interview to discuss how investors can capitalize on market rotation.
Soleno Therapeutics, Inc. (SLNO) Revenue Tops Expectations With $91.7M in Q4 Results, TD Cowen Maintains Buy
Soleno Therapeutics, Inc. (NASDAQ:SLNO) ranks among the most shorted stocks to buy according to analysts. On February 25, Soleno Therapeutics, Inc.
Wells Fargo Cuts PT on Soleno Therapeutics (SLNO) to $110 From $114 - Here's Why
Soleno Therapeutics, Inc. (NASDAQ:SLNO) is one of the best cheap biotech stocks to buy now. Wells Fargo cut the price target on Soleno Therapeutics, Inc.
12 Cheap Biotech Stocks to Buy Now
On February 27, Eli Casdin, Casdin Capital CEO, appeared on CNBC’s ‘Closing Bell’ to talk about the biotech sector.
11 Most Shorted Stocks to Buy According to Analysts
Although holes are starting to form, the stock market doesn't seem to be in danger of crashing just yet, with the S&P 500 down only 1% from its record high.
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Q4 2025 Earnings Call Transcript
Operator: Good afternoon, and thank you for standing by. Welcome to Soleno Therapeutics Fourth Quarter and Full Year 2025 Financial and Operating Results Conference Call and Webcast.
Hedge Fund Resource Center